omim.org

Online Mendelian Inheritance in Man (OMIM)

  • ️Wed Sep 25 2024

  1. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., Yamamoto, T. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644-1646, 1986. [PubMed: 3012781] [Full Text: https://doi.org/10.1126/science.3012781]

  2. Alvarado, D., Klein, D. E., Lemmon, M. A. ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. Nature 461: 287-291, 2009. [PubMed: 19718021] [Full Text: https://doi.org/10.1038/nature08297]

  3. Ameyaw, M.-M., Tayeb, M., Thornton, N., Folayan, G., Tariq, M., Mobarek, A., Evans, D. A. P., Ofori-Adjei, D., McLeod, H. L. Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J. Hum. Genet. 47: 172-175, 2002. [PubMed: 12166652] [Full Text: https://doi.org/10.1007/s100380200019]

  4. Anderson, L. A., Friedman, L., Osborne-Lawrence, S., Lynch, E., Weissenbach, J., Bowcock, A., King, M.-C. High-density genetic map of the BRCA1 region of chromosome 17q12-q21. Genomics 17: 618-623, 1993. [PubMed: 8244378] [Full Text: https://doi.org/10.1006/geno.1993.1381]

  5. Andrechek, E. R., Hardy, W. R., Girgis-Gabardo, A. A., Perry, R. L. S., Butler, R., Graham, F. L., Kahn, R. C., Rudnicki, M. A., Muller, W. J. ErbB2 is required for muscle spindle and myoblast cell survival. Molec. Cell. Biol. 22: 4714-4722, 2002. [PubMed: 12052879] [Full Text: https://doi.org/10.1128/MCB.22.13.4714-4722.2002]

  6. Bargmann, C. I., Hung, M.-C., Weinberg, R. A. The NEU oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226-230, 1986. [PubMed: 3945311] [Full Text: https://doi.org/10.1038/319226a0]

  7. Bostrom, J., Yu, S.-F., Kan, D., Appleton, B. A., Lee, C. V., Billeci, K., Man, W., Peale, F., Ross, S., Wiesmann, C., Fuh, G. Variants of the antibody Herceptin that interact with HER2 and VEGF at the antigen binding site. Science 323: 1610-1614, 2009. [PubMed: 19299620] [Full Text: https://doi.org/10.1126/science.1165480]

  8. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068, 2008. Note: Erratum: Nature 494: 506 only, 2013. [PubMed: 18772890] [Full Text: https://doi.org/10.1038/nature07385]

  9. Cancer Genome Project and Collaborative Group. Intragenic ERBB2 kinase mutations in tumours. Nature 431: 525-526, 2004. [PubMed: 15457249] [Full Text: https://doi.org/10.1038/431525b]

  10. Chan, R., Hardy, W. R., Laing, M. A., Hardy, S. E., Muller, W. J. The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development. Molec. Cell. Biol. 22: 1073-1078, 2002. [PubMed: 11809799] [Full Text: https://doi.org/10.1128/MCB.22.4.1073-1078.2002]

  11. Child, S. J., Miller, M. K., Geballe, A. P. Translational control by an upstream open reading frame in the HER-2/neu transcript. J. Biol. Chem. 274: 24335-24341, 1999. [PubMed: 10446211] [Full Text: https://doi.org/10.1074/jbc.274.34.24335]

  12. Cho, H.-S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., Jr., Leahy, D. J. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421: 756-760, 2003. [PubMed: 12610629] [Full Text: https://doi.org/10.1038/nature01392]

  13. Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., Levinson, A., Ullrich, A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with NEU oncogene. Science 230: 1132-1139, 1985. [PubMed: 2999974] [Full Text: https://doi.org/10.1126/science.2999974]

  14. Crone, S. A., Negro, A., Trumpp, A., Giovannini, M., Lee, K.-F. Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous system. Neuron 37: 29-40, 2003. [PubMed: 12526770] [Full Text: https://doi.org/10.1016/s0896-6273(02)01128-5]

  15. Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., Ross, J., Jr., Chien, K. R., Lee, K.-F. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nature Med. 8: 459-465, 2002. [PubMed: 11984589] [Full Text: https://doi.org/10.1038/nm0502-459]

  16. Dankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., Muller, W. J. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2) induced mammary tumorigenesis: implications for human breast cancer. Molec. Cell. Biol. 21: 1540-1551, 2001. [PubMed: 11238891] [Full Text: https://doi.org/10.1128/MCB.21.5.1540-1551.2001]

  17. De Boer, J. G. A new mutator phenotype in breast cancer? (Commentary) Proc. Nat. Acad. Sci. 99: 3368-3369, 2002. [PubMed: 11904400] [Full Text: https://doi.org/10.1073/pnas.082095799]

  18. De Placido, S., Carlomagno, C., De Laurentiis, M., Bianco, A. R. C-erbB2 expression predicts tamoxifen efficacy in breast cancer patients. Breast Cancer Res. Treat. 52: 55-64, 1998. [PubMed: 10066072] [Full Text: https://doi.org/10.1023/a:1006159001039]

  19. Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., Aaronson, S. A. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237: 178-182, 1987. [PubMed: 2885917] [Full Text: https://doi.org/10.1126/science.2885917]

  20. Doherty, J. K., Bond, C., Jardim, A., Adelman, J. P., Clinton, G. M. The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proc. Nat. Acad. Sci. 96: 10869-10874, 1999. [PubMed: 10485918] [Full Text: https://doi.org/10.1073/pnas.96.19.10869]

  21. Ehsani, A., Low, J., Wallace, R. B., Wu, A. M. Characterization of a new allele of the human ERBB2 gene by allele-specific competition hybridization. Genomics 15: 426-429, 1993. [PubMed: 8095488] [Full Text: https://doi.org/10.1006/geno.1993.1081]

  22. Escher, P., Lacazette, E., Courtet, M., Blindenbacher, A., Landmann, L., Bezakova, G., Lloyd, K. C., Mueller, U., Brenner, H. R. Synapses form in skeletal muscles lacking neuregulin receptors. Science 308: 1920-1923, 2005. [PubMed: 15976301] [Full Text: https://doi.org/10.1126/science.1108258]

  23. Francke, U. Personal Communication. New Haven, Connecticut 4/1988.

  24. Fukushige, S., Murotsu, T., Matsubara, K. Chromosomal assignment of human genes for gastrin, thyrotropin (TSH)-beta subunit and c-erb-2 by chromosome sorting combined with velocity sedimentation and southern hybridization. Biochem. Biophys. Res. Commun. 134: 477-483, 1986. [PubMed: 3511905] [Full Text: https://doi.org/10.1016/s0006-291x(86)80445-4]

  25. Fukushige, S.-I., Matsubara, K.-I., Yoshida, M., Sasaki, M., Suzuki, T., Semba, K., Toyoshima, K., Yamamoto, T. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Molec. Cell. Biol. 6: 955-958, 1986. [PubMed: 2430175] [Full Text: https://doi.org/10.1128/mcb.6.3.955-958.1986]

  26. Godinho, S. A., Picone, R., Burute, M., Dagher, R., Su, Y., Leung, C. T., Polyak, K., Brugge, J. S., Thery, M., Pellman, D. Oncogene-like induction of cellular invasion from centrosome amplification. Nature 510: 167-171, 2014. [PubMed: 24739973] [Full Text: https://doi.org/10.1038/nature13277]

  27. Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W. J., Inghirami, G., Giancotti, F. G. Beta-4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126: 489-502, 2006. [PubMed: 16901783] [Full Text: https://doi.org/10.1016/j.cell.2006.05.047]

  28. Hurtado, A., Holmes, K. A., Geistlinger, T. R., Hutcheson, I. R., Nicholson, R. I., Brown, M., Jiang, J., Howat, W. J., Ali, S., Carroll, J. S. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 456: 663-666, 2008. Note: Erratum: Nature 457: 1168 only, 2009. [PubMed: 19005469] [Full Text: https://doi.org/10.1038/nature07483]

  29. Jackson-Fisher, A. J., Bellinger, G., Ramabhadran, R., Morris, J. K., Lee, K.-F., Stern, D. F. ErbB2 is required for ductal morphogenesis of the mammary gland. Proc. Nat. Acad. Sci. 101: 17138-17143, 2004. [PubMed: 15569931] [Full Text: https://doi.org/10.1073/pnas.0407057101]

  30. Jones, R. B., Gordus, A., Krall, J. A., MacBeath, G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439: 168-174, 2006. [PubMed: 16273093] [Full Text: https://doi.org/10.1038/nature04177]

  31. Jordan, N. V., Bardia, A., Wittner, B. S., Benes, C., Ligorio, M., Zheng, Y., Yu, M., Sundaresan, T. K., Licausi, J. A., Desai, R., O'Keefe, R. M., Ebright, R. Y., and 12 others. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature 537: 102-106, 2016. [PubMed: 27556950] [Full Text: https://doi.org/10.1038/nature19328]

  32. Kaneko, Y., Homma, C., Maseki, N., Sakurai, M., Toyoshima, K., Yamamoto, T. Human c-erbB-2 remains on chromosome 17 in band q21 in the 15;17 translocation associated with acute promyelocytic leukemia. Jpn. J. Cancer Res. 78: 16-19, 1987. [PubMed: 3102433]

  33. Kawasaki, H., Taira, K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature 431: 211-217, 2004. Note: Erratum: Nature 431: 878 only, 2004. Note: Retraction: Nature 441: 1176 only, 2006. [PubMed: 15311210] [Full Text: https://doi.org/10.1038/nature02889]

  34. Kun, Y., How, L. C., Hoon, T. P., Bajic, V. B., Lam, T. S., Aggarwal, A., Sze, H. G., Bok, W. S., Yin, W. C., Tan, P. Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor. Hum. Molec. Genet. 12: 3245-3258, 2003. [PubMed: 14570715] [Full Text: https://doi.org/10.1093/hmg/ddg347]

  35. Le, T.-L., Galmiche, L., Levy, J., Suwannarat, P., Hellebrekers, D. M. E. I., Morarach, K., Boismoreau, F., Theunissen, T. E. J., Lefebvre, M., Pelet, A., Martinovic, J., Gelot, A., and 25 others. Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans. J. Clin. Invest. 131: e145837, 2021. [PubMed: 33497358] [Full Text: https://doi.org/10.1172/JCI145837]

  36. Lin, W., Sanchez, H. B., Deerinck, T., Morris, J. K., Ellisman, M., Lee, K. F. Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc. Nat. Acad. Sci. 97: 1299-1304, 2000. [PubMed: 10655525] [Full Text: https://doi.org/10.1073/pnas.97.3.1299]

  37. Liu, S., Liu, W., Jakubczak, J. L., Erexson, G. L., Tindall, K. R., Chan, R., Muller, W. J., Adhya, S., Garges, S., Merlino, G. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis. Proc. Nat. Acad. Sci. 99: 3770-3775, 2002. [PubMed: 11867754] [Full Text: https://doi.org/10.1073/pnas.052710299]

  38. Mehta, A., Trotta, C. R., Peltz, S. W. Derepression of the Her-2 uORF is mediated by a novel post-transcriptional control mechanism in cancer cells. Genes Dev. 20: 939-953, 2006. [PubMed: 16598037] [Full Text: https://doi.org/10.1101/gad.1388706]

  39. Mehta, R. R., McDermott, J. H., Hieken, T. J., Marler, K. C., Patel, M. K., Wild, L. D., Das Gupta, T. K. Plasma c-erbB2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy. J. Clin. Oncol. 16: 2409-2416, 1998. [PubMed: 9667258] [Full Text: https://doi.org/10.1200/JCO.1998.16.7.2409]

  40. Menendez, J. A., Vellon, L., Mehmi, I., Oza, B. P., Ropero, S., Colomer, R., Lupu, R. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc. Nat. Acad. Sci. 101: 10715-10720, 2004. [PubMed: 15235125] [Full Text: https://doi.org/10.1073/pnas.0403390101]

  41. Morris, J. K., Lin, W., Hauser, C., Marchuk, Y., Getman, D., Lee, K.-F. Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development. Neuron 23: 273-283, 1999. [PubMed: 10399934] [Full Text: https://doi.org/10.1016/s0896-6273(00)80779-5]

  42. Muleris, M., Almeida, A., Malfoy, B., Dutrillaux, B. Assignment of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) to human chromosome band 17q21.1 by in situ hybridization. Cytogenet. Cell Genet. 76: 34-35, 1997. [PubMed: 9154120] [Full Text: https://doi.org/10.1159/000134507]

  43. Negro, A., Brar, B. K., Gu, Y., Peterson, K. L., Vale, W., Lee, K.-F. erbB2 is required for G protein-coupled receptor signaling in the heart. Proc. Nat. Acad. Sci. 103: 15889-15893, 2006. [PubMed: 17043217] [Full Text: https://doi.org/10.1073/pnas.0607499103]

  44. Ozcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hubner, N., Chien, K. R., Birchmeier, C., Garratt, A. N. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc. Nat. Acad. Sci. 99: 8880-8885, 2002. [PubMed: 12072561] [Full Text: https://doi.org/10.1073/pnas.122249299]

  45. Papewalis, J., Nikitin, A. Y., Rajewsky, M. F. G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene. Nucleic Acids Res. 19: 5452 only, 1991. [PubMed: 1681519] [Full Text: https://doi.org/10.1093/nar/19.19.5452-a]

  46. Pegram, M. D., Finn, R. S., Arzoo, K., Beryt, M., Pietras, R. J., Slamon, D. J. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene 15: 537-547, 1997. [PubMed: 9247307] [Full Text: https://doi.org/10.1038/sj.onc.1201222]

  47. Pietras, R. J., Pegram, M. D., Finn, R. S., Maneval, D. A., Slamon, D. J. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene 17: 2235-2249, 1998. [PubMed: 9811454] [Full Text: https://doi.org/10.1038/sj.onc.1202132]

  48. Popescu, N. C., King, C. R., Kraus, M. H. Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32. Genomics 4: 362-366, 1989. [PubMed: 2565881] [Full Text: https://doi.org/10.1016/0888-7543(89)90343-1]

  49. Qiu, Y., Ravi, L., Kung, H.-J. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393: 83-85, 1998. [PubMed: 9590694] [Full Text: https://doi.org/10.1038/30012]

  50. Roses, A. D. Pharmacogenetics and drug development: the path to safer and more effective drugs. Nature Rev. Genet. 5: 645-656, 2004. [PubMed: 15372086] [Full Text: https://doi.org/10.1038/nrg1432]

  51. Semba, K., Kamata, N., Toyoshima, K., Yamamoto, T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Nat. Acad. Sci. 82: 6497-6501, 1985. [PubMed: 2995967] [Full Text: https://doi.org/10.1073/pnas.82.19.6497]

  52. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989. [PubMed: 2470152] [Full Text: https://doi.org/10.1126/science.2470152]

  53. Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J., Norton, L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New Eng. J. Med. 344: 783-792, 2001. [PubMed: 11248153] [Full Text: https://doi.org/10.1056/NEJM200103153441101]

  54. Tan, M., Jing, T., Lan, K.-H., Neal, C. L., Li, P., Lee, S., Fang, D., Nagata, Y., Liu, J., Arlinghaus, R., Hung, M.-C., Yu, D. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Molec. Cell 9: 993-1004, 2002. [PubMed: 12049736] [Full Text: https://doi.org/10.1016/s1097-2765(02)00510-5]

  55. Tapinos, N., Ohnishi, M., Rambukkana, A. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nature Med. 12: 961-966, 2006. Note: Erratum: Nature Med. 12: 1100 only, 2006. [PubMed: 16892039] [Full Text: https://doi.org/10.1038/nm1433]

  56. van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., Nusse, R. NEU-protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. New Eng. J. Med. 319: 1239-1245, 1988. [PubMed: 2903446] [Full Text: https://doi.org/10.1056/NEJM198811103191902]

  57. Vermeer, P. D., Einwalter, L. A., Moninger, T. O., Rokhlina, T., Kern, J. A., Zabner, J., Welsh, M. J. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 422: 322-326, 2003. [PubMed: 12646923] [Full Text: https://doi.org/10.1038/nature01440]

  58. Xie, D., Shu, X. O., Deng, Z., Wen, W.-Q., Creek, K. E., Dai, Q., Gao, Y.-T., Jin, F., Zheng, W. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J. Nat. Cancer Inst. 92: 412-417, 2000. [PubMed: 10699071] [Full Text: https://doi.org/10.1093/jnci/92.5.412]

  59. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., Toyoshima, K. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319: 230-234, 1986. [PubMed: 3003577] [Full Text: https://doi.org/10.1038/319230a0]

  60. Yang-Feng, T. L., Schechter, A. L., Weinberg, R. A., Francke, U. Oncogene from rat neuro/glioblastomas (human gene symbol NGL) is located on the proximal long arm of human chromosome 17 and EGFR is confirmed at 7p13-q11.2. (Abstract) Cytogenet. Cell Genet. 40: 784 only, 1985.

  61. Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T. J., Hung, M.-C. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Molec. Cell 2: 581-591, 1998. [PubMed: 9844631] [Full Text: https://doi.org/10.1016/s1097-2765(00)80157-4]